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ABSTRACT
The repair of DNA by nucleotide excision repair
(NER) and non-homologous end joining (NHEJ) is
essential for maintenance of genomic integrity and
cell viability. Examination of NHEJ and NER in vitro
using cell-free extracts has led to a deeper under-
standing of the biochemical mechanisms that
underlie these processes. Current methods for
production of whole-cell extracts (WCEs) to inves-
tigate NER and NHEJ start with one or more liters of
culture containing 1–5310
9 cells. Here, we describe
a small-scale method for production of WCE that
can be used to study NER. We also describe a rapid,
small-scale method for the preparation of WCE that
can be used in the study of NHEJ. These methods
require less time, 20- to 1000-fold fewer cells than
large-scale extracts, facilitate examination of
numerous samples and are ideal for such appli-
cations as the study of host–virus interactions and
analysis of mutant cell lines.
INTRODUCTION
The chemistry of DNA makes it highly resistant, but not
impervious, to damage. Environmental and intracellular
agents can cause lesions that can lead to misinformation
or break the ﬂow of genetic information. In addition,
DNA replication and somatic cell recombination intro-
duce double-strand breaks (DSBs) in DNA that challenge
genomic continuity. To maintain the proper ﬂow of
correct genetic information DNA repair mechanisms
have evolved to identify and repair base lesions and
strand breaks.
The nucleotide excision repair (NER) pathway
repairs bulky DNA adducts or intrastrand cross-links
caused by exposure to UV light or alkylating agents.
This process encompasses two sub-pathways that survey
the entire genome (global genome repair, GGR) and the
transcriptionally active part of the genome (transcription
coupled repair, TCR) for base lesions that block the
elongating RNA polymerase (1,2).
The importance of DSB repair is highlighted by the
observation that failure to repair even a single DSB can
result in the loss of genetic information, chromosomal
translocation and even cell death (3). Non-homologous
end joining (NHEJ) is an important pathway employed by
mammalian cells in the repair of adventitious DSBs and
also for the repair of programmed DSBs made during
somatic cell recombination (2–4). Defects in NHEJ can
result in gross chromosomal aberrations such as translo-
cations and studies in mouse models have shown that such
defects can lead to events that initiate or propagate
tumorigenesis (3,4).
Investigation of the molecular mechanisms that underlie
NER and NHEJ was stimulated by the development
of cell-free extracts that supported these processes in vitro
(5–8). Unfortunately, the requirement of 1–5 10
9 cells
for these methods limits the utility of standard protocols.
Here, we report the development of small-scale, cell-free
extract protocols to study NER and NHEJ in vitro.
MATERIALS AND METHODS
Cellculture
HeLa cells (Biovest International Inc., National Cell
Culture Center) were grown in suspension to 10
6 cells/ml
in Joklik’s MEM, 5% newborn calf serum, 100U/ml
penicillin and 100mg/ml streptomycin (PenStrep). 293 cells
were cultured as monolayers in EMEM, 10% fetal bovine
serum (FBS) and PenStrep in 25cm
2 ﬂasks. CHO AA8
(wild type), CHO UV5 (XPD) (gifts from Dr Michael
Seidman) and CHO UV41 (XPF) (ATCC) cells were
grown in minimal essential medium alpha modiﬁcation,
10% FBS and PenStrep in 175cm
2 ﬂasks. Adherent CHO
AA8 cells were grown to large scale using CellSTACK
culture chambers (Corning); a 10-layer chamber yields
 10
9 cells.
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293 monolayers were grown in 25cm
2 ﬂasks; the medium
was removed and was replaced with 1ml fresh media with
virus (MOI=10p.f.u./cell). Virus was allowed to adsorb
(2h, 378C, with gentle agitation) after which the inoculum
was aspirated away and replaced with fresh medium.
Infected cells were cultured for times indicated.
Large-scale extracts forNER
Large-scale preparations of NER-competent whole-cell
extracts (WCE) were carried out essentially as previously
described (8–10). Brieﬂy, cells were harvested and rinsed
with phosphate-buﬀered saline (PBS). Subsequent steps
were carried out at 48C. Cells were resuspended in four
packed cell volumes (PCV) of hypotonic lysis buﬀer
(HLB: 10mM Tris–HCl pH 8.0, 1mM EDTA) with 5mM
DTT and incubated on ice for 20min. Protease inhibitors
were added to 1mM PMSF, 10mg/ml aprotinin, 5mg/ml
leupeptin and 100mg/ml soybean trypsin inhibitor and
cells were homogenized [20 strokes, Potter–Elvehjem 10ml
glass tube with a Teﬂon pestle (Kontes)]. The homogenate
was transferred to a beaker in an ice bath. Using a
magnetic stirrer, 4 PCV of sucrose-glycerol buﬀer [50mM
Tris–HCl pH 8, 10mM MgCl2, 2mM DTT, 25% sucrose
(w/v), 50% glycerol (v/v)] and 1 PCV of saturated
(NH4)2SO4 (pH 7.0) were added and the solution was
mixed slowly for 30min. Ultracentrifugation (SW 41, 3h,
125000g) was used to remove solid material. A total of
0.33g per ml ﬁnely ground solid (NH4)2SO4 was added to
the supernatant with 10ml of 1M NaOH/g of (NH4)2SO4
to maintain neutral pH and the extract was allowed to stir
for 30min. Precipitated proteins were collected (centrifu-
gation, 45min, 12000g,4 8C) and the pellet was resus-
pended in a minimal volume of NER-dialysis buﬀer
(25mM HEPES pH 7.9, 100mM KCl, 12mM MgCl2,
0.5mM EDTA, 2mM DTT, 12% glycerol), dialyzed
overnight against NER-dialysis buﬀer and insoluble mate-
rial was removed [microcentrifugation, 10min, 11337g
(13000r.p.m.), 48C]. The resulting WCE was aliquoted,
frozen on liquid nitrogen and stored at  808C. Protein
concentration: 15–20mg/ml by BCA (Pierce Chemical
Co.) or Bradford (Bio-Rad) protein assay systems.
Large-scale extracts forNHEJ
HeLa WCE was prepared essentially as previously
described (5). Brieﬂy, 5 10
9 cells were harvested,
washed twice with PBS, resuspended in two PCV of
HLB with 1mM DTT and held on ice for 20min. Cells
were opened by dounce homogenization in the presence of
protease inhibitors (1mM PMSF, 2.2ng/ml aprotinin,
1ng/ml leupeptin, 1ng/ml pepstatin A and 1ng/ml
chymostatin). High salt buﬀer (HSB: 83.5mM Tris pH
7.5, 1.65M KCl, 3.3mM EDTA, 1mM DTT) was added
to adjust the ﬁnal salt concentration to 0.33M KCl and
the sample was held on ice for 20min. The sample was
subject to ultracentrifugation (170000g, 3h, 48 C,
Beckman SW41 Ti rotor), the supernatant was collected
and dialyzed against 20mM Tris pH 8.0, 0.1M KOAc,
20% glycerol, 0.5mM EDTA and 1mM DTT for 2h.
The resulting WCE was snap frozen on liquid nitrogen,
and stored at  808C. Protein concentration: 15–20mg/ml
by Bradford assay.
Mini-NER–WCE (mNER–WCE)
Extracts were prepared from 5 10
7 CHO AA8, XPD or
XPG cells (175cm
2 culture area) using a modiﬁed Manley
procedure (8). Cells were harvested at 90–95% conﬂuency
by addition of trypsin to cover the plate surface and
removal of the excess trypsin. The cells were resuspended
in 40ml of medium and pelleted (1000g, 10min).
The pellet was washed with 1ml cold PBS, transferred
to a silanized Eppendorf tube, pelleted [microcentrifuga-
tion, 200g (1600r.p.m.), 5min, Baxter Heraeus Biofuge
13] and lyzed by freezing on liquid nitrogen and thawing
rapidly at 378C. Cell pellets can also be stored at  808C
until extract preparation is convenient. Subsequent steps
were carried out at 48C and DTT was added fresh to each
buﬀer on the day of use. The cell pellet (100ml) was
re-suspended with 10–20 strokes of a P-1000 pipette in
4 PCV (400ml) of HLB with 5mM DTT, 2mg/ml
aprotinin, 10mg/ml leupeptin, 1mM PMSF and 100mg/
ml soybean trypsin inhibitor and lysis was measured by
trypan blue dye exclusion. Four PCV of sucrose–glycerol
buﬀer were added and mixed slowly using a wide-bore
pipette tip. One PCV (100ml) of saturated (NH4)2SO4,p H
7.0 was added slowly and mixed by rotation (30min, 48C).
Insoluble material was removed [microcentrifugation,
20min, 11500g (13000r.p.m.), 48C] and the supernatant
( 800ml) was transferred to a fresh silanized Eppendorf
tube. Solid (NH4)2SO4 (ﬁnely ground) was added at 0.33g
of ammonium sulfate per milliliter of solution (0.264g)
with 1ml of 0.1M NaOH per 10mg of (NH4)2SO4 to
maintain pH 7.0 and the solution was mixed by rota-
tion (20min, 48C). Precipitated proteins were collected
[microcentrifugation, 20min, 11500g (13000r.p.m.), 48C]
and resuspended in 10ml of NER dialysis buﬀer and
dialyzed against 100ml of NER dialysis buﬀer (6h to
overnight, 48C) using Slide-A-Lyzer mini dialysis units
10000 MWCO (Pierce, presoaked 20min in deionized
water to remove glycerol) to yield 80–100ml of mNER-
WCE per 100ml PCV. Extracts may be concentrated by
placing the dialysis unit on a bed of dry CM-Sephadex
(Pharmacia) until the volume is  2/3–1/2 ( 15–30min).
We consistently observed increased excision activity using
this concentration method, however the protein concen-
tration does not increase as much as would be expected for
a given volume reduction, presumably due to loss of
protein on the dialysis membrane. mNER-WCE was
aliquoted and frozen on liquid nitrogen and stored at
 808C. Protein concentration: 13 –14mg/ml by Bradford
assay.
One hundred andtwenty-minute mini-NHEJ–WCE
(mNHEJ–WCE)
Adherent cells were harvested at 70–80% conﬂuency using
a cell scraper, collected (centrifugation, 5min, 800g,4 8C),
washed twice in PBS, frozen on dry ice and stored at
 808C. Frozen cell pellets were resuspended in 2 PCV of
HLB, incubated on ice for 20min and lyzed by vortexing
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2min, RT) and the supernatant was retained. Nuclei were
resuspended in 1 PCV of nuclear extract buﬀer (25mM
Tris pH 8.0, 0.33M KCl, 1.5mM EDTA) and incubated
on ice for 20min. The retained supernatant was added
back to the nuclei and cell debris was removed (micro-
centrifugation, 10min, 16500g,4 8C). The resulting super-
natant was collected as mNHEJ–WCE and used without
dialysis. Protein concentration: 5–10mg/ml by Bradford
assay. MNHEJ–WCE was aliquoted and frozen on liquid
nitrogen and stored at  808C up to 3 months without
signiﬁcant loss of activity.
Nucleotide excisionassay
Repair substrate: oligonucleotides were synthesized using
standard phosphoramidite chemistry on an Applied Bio-
systems Model 3400 DNA/RNA synthesizer, puriﬁed by
SAX HPLC and desalted on a C-18 SEP PAK cartridge
(Waters, Inc.). To prepare the platinated oligonucleotide:
26.5nmol of oligonucleotide was incubated with 54nmol
cis-diamminedichloroplatinum (II) in 1.5ml of 10mM
Tris pH 8.0, 1mM EDTA (378C, 16h) then desalted
on a C-18 SEP PAK cartridge, puriﬁed by SAX HPLC
(linear gradient of 0.0–0.5M NaCl in 50mM Tris, pH 7.8
with 20% acetonitrile) and conﬁrmed by MALDI-TOF
mass spectrometry (m/z calculated.: 4078.64, observed:
4079.36). The platinated oligonucleotide was
32P labeled
with T4-polynucleotide kinase (T4 PNK, New England
Biolabs) and annealed with its complementary strand to
create platinated duplex X (Table 1). The labeled substrate
used to monitor NER was prepared by phosphorylation
and ligation of component duplexes A F+X (Table 1).
Ligation products were gel puriﬁed (6% denaturing
PAGE) and full-length individual strands were isolated
then re-annealed by heating (908C, 5min), slow cooling to
<308C and stored (48C). Nucleotide excision reactions
were carried out essentially as previously described (10).
Brieﬂy, reactions (25ml) were assembled in silanized tubes
in 25mM HEPES, pH 7.9, 4.4mM MgCl2, 0.1mM
EDTA, 1mM DTT, 70mM KCl, 4mM ATP, 200mg/ml
bovine serum albumin (BSA), 2.4–4.8% glycerol, 45ng of
pGEM3Z DNA and 5ml of extract (90–100mg of large-
scale extract or 65–70mg of mNER–WCE), incubated
on ice for 10min, started by addition of 10 fmol of
32P-labeled substrate and incubated at 308C for 1h.
Reactions were stopped by addition of 10mg of proteinase
K in 0.3% SDS and deproteinized for 15min at 378C.
Reactions were extracted once with phenol/chloroform/
isoamyl alcohol (25:24:1 v/v) and once with chloroform/
isoamyl alcohol (24:1). DNA was ethanol precipitated and
the reaction products were separated by electrophoresis
(10% sequencing gel). The gel was ﬁxed (5% acetic acid,
5% methanol, 90% water) for 5min and dried. Excision
products were quantiﬁed using Image Quant 5.2 software.
Quantiﬁcation of excision products was done on samples
in which saturation of the signal had not been reached.
NHEJ assay
Assays for NHEJ were carried out as described in
Refs (5,11). Brieﬂy, reactions (10ml) were carried out in
50mM HEPES pH 8.0, 40mM KOAc, 0.5mM Mg(OAc)2,
1mM ATP, 1mM DTT, 0.1mg/ml BSA and HindIII-
linearized 50-
32P-labeled pBluescript KS+ DNA (10ng)
with 20–40mg of WCE or NHEJ–mWCE. Reactions were
incubated for 2h at 378C, stopped by the addition of
deproteinization solution (2ml, 10mg/ml Proteinase K,
50mM EDTA, 0.1M Tris pH 7.5, 2.5% SDS) and
deproteinized for 30min at 378C. Products were separated
by agarose gel electrophoresis (0.6%, TAE) and visualized
by autoradiography. Rabbit anti-human-XRCC4 anti-
serum (Serotec, AHP387) was used to neutralize NHEJ
in vitro at the speciﬁed dilutions. Wortmannin (SIGMA)
was used at the speciﬁed concentrations.
RESULTS
Mini-WCEs for thestudy of NER invitro: mini-NER–WCE
We have developed a mini-extract protocol that can be
used in the study of NER, which reduces the number of
cells required for analysis by 20-fold. As shown in
Figure 1, when a DNA substrate that carries a site-
speciﬁc 1,3 platinum lesion is treated with large-scale
extracts prepared in the traditional manner from 10
9 cells
we observe the expected cleavage events 50 and 30 of the
platinum lesion to produce 25–30nt long excision
products. When the same substrate is treated with mini-
NER–WCE (mNER–WCE) prepared from 5 10
7 cells
we observed the same cleavage near the platinum
modiﬁcation, which indicates that the mNER–WCE
contains all of the factors necessary for recognition and
excision of a platinum lesion.
Because the mNER–WCE is less concentrated than
large-scale extracts the observed excision activity was
lower than that observed with the large-scale extracts.
Figure 1 shows that concentration of the mNER–WCE
increased the excision activity and made it comparable to
the large-scale extract.
To test the dependence of the mNER–WCE-catalyzed
excision events on known excision repair factors, we pre-
pared mNER–WCE from cells deﬁcient in XPD or XPG.
















Ligation of these duplexes mediated by complementary overhangs
(bold) resulted in ordering of the fragments as A-B-C-X-D-E-F.
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cells is unable to excise the platinum lesion. Combining
the XPD and XPG mini-extracts restores excision activity.
These data show that extracts prepared using our small-
scale mNER–WCE method are catalytically active for
NER and that this method is applicable to a variety of
cell lines.
Mini-WCE forthestudy of NHEJ in vitro:120-min
mini-NHEJ–WCE
Establishment of an in vitro DNA ligase IV-dependent
NHEJ assay enabled examination of the molecular mecha-
nism of the ligation step of NHEJ. As shown in Figure 2A,
NHEJ–WCE prepared using the conventional large-scale
method catalyze end joining, which is sensitive to the
PI3-kinase inhibitors LY294002 and wortmannin. End
joining catalyzed by the large-scale NHEJ–WCE is also
sensitive to treatment with neutralizing anti-XRCC4 anti-
bodies (lane 3) but not to treatment with control anti-GST
antibodies (lane 4), which demonstrates a speciﬁc require-
ment for the XRCC4 protein. The data presented in
Figure 2 are consistent with the original description of this
method (5).
To facilitate our investigation of the molecular mecha-
nism of NHEJ we developed a mini-extract protocol that
reduces the number of cells required for analysis from
5 10
9 (5) to 5 10
6 cells. Mini–NHEJ–WCEs were
prepared from 293 cells and end joining was assayed for
DNA end joining. As shown in Figure 2B, treatment with
either anti-XRCC4 antibodies, LY294002 or wortmannin
resulted in a signiﬁcant decrease in ligation eﬃciency
(Figure 2B), which indicated a requirement for both
XRCC4 and DNA-PKcs and identiﬁed the DNA end
joining catalyzed by mNHEJ-WCE as bona ﬁde mamma-
lian NHEJ. Treatment with control anti-GST antibodies
had no eﬀect and similar results were obtained with mini-
extracts prepared from HeLa cells (data not shown).
Inhibition ofNHEJ by human adenovirus (Ad5)
Studies have shown that infection with human Ad5 results
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Figure 1. Mini-NER Whole-Cell extracts (mNER–WCE) are active for
excision repair. Top: Schematic diagram of the substrate containing a
32P label near a single 1,3 d-(GTG) platinum lesion. Filled circle
indicates
32P label. Pt denoted location of platinum lesion. Bottom: The
substrate was incubated with wild-type (AA8, lanes 2–4), NER mutant
extracts (XPD and XPG, lanes 5 and 6), or complemented XPD and
XPG extracts (D+G, lane 7), analyzed on a 10% sequencing gel and
quantiﬁed as described. L, large-scale extract; M, mNER–WCE; [M],
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Figure 2. Mini-NHEJ extracts (mNHEJ–WCE) are active for NHEJ
in vitro.( A) Large-scale whole cell extracts (Lg scale NHEJ–WCE,
40mg) prepared from HeLa cells was assayed in vitro for end joining in
the presence or absence of neutralizing anti-XRCC4 antibodies (lane 3
aX 1:300), control anti-GST antibodies (lane 4 aG 1:50), LY294002
(lanes 6 and 7, 2 and 10mM) or wortmannin (Wort. lanes 9 and 10, 0.3
and 1mM). (B) Mini-NHEJ–WCE (mNHEJ–WCE, 40mg) prepared
from 293 cells was assayed in vitro for end joining in the presence or
absence of neutralizing anti-XRCC4 antibodies (aX lanes 3 and 4,
1:1500 and 1:300), LY294002 (lanes 6 and 7, 2 and 10mM) or
wortmannin (Wort. lanes 9 and 10, 0.3 and 1mM).
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where we carried out small-scale infections and observed
the inhibition of NHEJ in vitro in extracts prepared
from Ad5-infected cells. We also used the mNHEJ–WCE
protocol to facilitate mutational analysis to assess the role
of early viral proteins in inhibition of NHEJ.
Ad5 infections of 293 cells were carried out in 5ml
ﬂasks and mNHEJ–WCE was prepared to observe inhi-
bition of NHEJ over 48h. As shown in Figure 3A, we
observed no change in the NHEJ catalyzed by mNHEJ–
WCE prepared from mock-infected cells isolated over
48h, while in Ad5-infected cells, NHEJ activity declined
within 24h post-infection.
The adenoviral E1b 55k–E4 34k protein complex and
the E4 11k protein inhibit viral genome concatenation
mediated by NHEJ in vivo and the E1b 55k–E4 34k
protein complex additionally inhibits NHEJ on other
substrates (12–16). The mechanism of NHEJ inhibition
by the E1b 55k–E4 34k complex has been found to be
degradation of DNA ligase IV (16) and complementation
of extracts prepared from Ad5-infected cells partially
restores NHEJ in vitro (data not shown). In contrast,
the mechanism of E4 11k inhibition of NHEJ in vivo
remains an open question. To assess the potential of the
adenovirus early protein E4 11k to inhibit the ligation step
of NHEJ we used the mini-NHEJ–WCE protocol to
examine the eﬀects of infection with various early region 4
(E4)-deletion mutants of Ad5 (Figure 3B). As shown in
Figure 3C, infection with E4-deletion mutant dl1004,
which lacks most of the E4 region, demonstrates that
inhibition of NHEJ requires expression of E4 proteins.
E4-deletion mutants dl1014 and dl1015 do not express E4
34k and provide a clear look at eﬀect of E4 11k on NHEJ.
Comparison of NHEJ catalyzed by mWCE prepared from
293 cells infected with either E4 11k-deﬁcient (dl1014) or
E4 11k-expressing (dl1015) virus (Figure 3C) indicated
that expression of E4 11k had only a slight eﬀect, if any,
on DNA ligase IV-dependent joining in vitro. These data
show that while E4 11k is capable of inhibiting NHEJ on
the viral genome in vivo, the factors required for DNA
ligase IV-dependent end joining are not impaired.
DISCUSSION
Here we report the development of a small-scale cell
extract protocol that can be used to prepare extracts for
the study of NER in vitro. This method uses 20-fold fewer
cells than previously published methods (8–10). We show
that mNER–WCEs produce plantinated lesion-directed
cleavages that are characteristic of the NER pathway and
require participation of known NER factors XPD and
XPG. Importantly, this method can be used for com-
plementation analysis of NER-deﬁcient cell lines or
to screen the participation of NER factors in the repair
of diﬀerent DNA lesions.
We also describe a rapid, small-scale method for the
production of NHEJ-competent WCEs. This method
reduces the number of cells used to prepare extracts for
NHEJ analysis from 5 10
9 cells used in the large-scale
method of Baumann and West (5) to as few as 5 10
6
cells. While this is not the ﬁrst report of a small-scale
NHEJ assay, the method described by Diggle et al. (17)
requires 0.5 1 10
8 cells and requires ultracentrifuga-
tion and dialysis. The method described here requires
10- to 20-fold fewer cells than the Diggle method, takes
 120min and does not require ultracentrifugation or
dialysis.
The usefulness of both of these methods comes
primarily from a reduction in the number of cells required
to produce the mini-extracts. Elimination of ultracentri-
fugation steps reduces the time required for extract
preparation and relaxes the need for specialized equip-
ment. In the 120-min mNHEJ-WCE protocol, elimination
of the dialysis step saves time and reduces sample manipu-
lation. All of these improvements make the mini-extract
protocols more amenable to multiple sample preparation
and examination of numerous variables. As we show in
Figure 3, the mNHEJ–WCE protocol is particularly useful
in the examination of host–virus interactions where large-
scale infections would be cumbersome.
Ad5
Infection 
time (hrs)  4 8  12  24  48  4 8 12  24 48 - 
Mock
A
B  3000   k kb b    2000   k kb b    1000   k kb b    0 
ORF1  ORF2  ORF3  ORF4  ORF6  ORF7  Ad5 
dl1014  ORF1  O OR RF F2 2    ORF4  ORF6   O OR RF F7 7   
dl1015  ORF1  O OR RF F2 2    ORF3  ORF4  ORF6  O OR RF F7 7   
dl1004 ORF1  O OR RF F3 3    O OR RF F4 4    O OR RF F6 6    O OR RF F7 7    ORF2 
ORF3 
C 
- M Ad5 14 15 04
Figure 3. Utility of mini-NHEJ WCE: time course and mutational
analysis of NHEJ inhibition during human adenovirus (Ad5) infection.
(A) Time course. 293 cells were cultured in T25 ﬂasks, Ad5- or Mock-
infected and grown for the indicated time post-infection. At each time
point, cells from a single T25 ﬂask were harvested and stored at  808C.
At the end of the time course, mWCEs were prepared and 40mgo f
mWCE was assayed for in vitro NHEJ activity. (B) Ad5 E4-deletion
mutants used in this study. White spaces denote deletions. Only
complete ORFs are expressed. All other adenoviral genes are intact.
(C) Mutational analysis. NHEJ catalyzed by mWCEs prepared from
293 cells infected with E4-deletion mutants. MNHEJ–WCE (40g)
prepared from Mock- or Ad5-infected 293 cells or from 293 cells
infected with the indicated E4-deletion mutants was assayed for in vitro
NHEJ activity. ( ) indicates no mWCE.
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